179 related articles for article (PubMed ID: 29533868)
21. Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.
Liskamp CP; Janssens GO; Bussink J; Melchers WJ; Kaanders JH; Verhoef CG
Head Neck; 2016 Dec; 38(12):1780-1787. PubMed ID: 27248701
[TBL] [Abstract][Full Text] [Related]
22. Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers.
Smith EM; Rubenstein LM; Haugen TH; Hamsikova E; Turek LP
Cancer Causes Control; 2010 Sep; 21(9):1369-78. PubMed ID: 20401530
[TBL] [Abstract][Full Text] [Related]
23. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
[TBL] [Abstract][Full Text] [Related]
24. Case-control study of human papillomavirus and oropharyngeal cancer.
D'Souza G; Kreimer AR; Viscidi R; Pawlita M; Fakhry C; Koch WM; Westra WH; Gillison ML
N Engl J Med; 2007 May; 356(19):1944-56. PubMed ID: 17494927
[TBL] [Abstract][Full Text] [Related]
25. High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer.
Nichols AC; Palma DA; Chow W; Tan S; Rajakumar C; Rizzo G; Fung K; Kwan K; Wehrli B; Winquist E; Koropatnick J; Mymryk JS; Yoo J; Barrett JW
JAMA Otolaryngol Head Neck Surg; 2013 Jun; 139(6):617-22. PubMed ID: 23787421
[TBL] [Abstract][Full Text] [Related]
26. Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population.
Chaturvedi AK; D'Souza G; Gillison ML; Katki HA
Oral Oncol; 2016 Sep; 60():61-7. PubMed ID: 27531874
[TBL] [Abstract][Full Text] [Related]
27. Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
Fullerton ZH; Butler SS; Mahal BA; Muralidhar V; Schoenfeld JD; Tishler RB; Margalit DN
Cancer; 2020 Apr; 126(7):1424-1433. PubMed ID: 31930488
[TBL] [Abstract][Full Text] [Related]
28. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
29. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
Kusters JMA; Diergaarde B; Ness A; Schim van der Loeff MF; Heijne JCM; Schroeder L; Hueniken K; McKay JD; Macfarlane GJ; Lagiou P; Lagiou A; Polesel J; Agudo A; Alemany L; Ahrens W; Healy CM; Conway DI; Robinson M; Canova C; Holcátová I; Richiardi L; Znaor A; Pring M; Thomas S; Hayes DN; Liu G; Hung RJ; Brennan P; Olshan AF; Virani S; Waterboer T
Int J Cancer; 2024 Jan; 154(2):389-402. PubMed ID: 37694289
[TBL] [Abstract][Full Text] [Related]
31. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
[TBL] [Abstract][Full Text] [Related]
32. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M; Maddalo M; Corvò R; Pirtoli L; Paiar F; Lastrucci L; Stefanacci M; Belgioia L; Crociani M; Vecchio S; Bonomo P; Bertocci S; Borghetti P; Pasinetti N; Triggiani L; Costa L; Tonoli S; Grisanti S; Magrini SM
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):462-472. PubMed ID: 27986347
[TBL] [Abstract][Full Text] [Related]
33. Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV.
Andrews E; Seaman WT; Webster-Cyriaque J
Oral Oncol; 2009 Jun; 45(6):486-91. PubMed ID: 19027350
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
[TBL] [Abstract][Full Text] [Related]
35. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
36. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
[TBL] [Abstract][Full Text] [Related]
37. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
38. The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma.
Martel M; Alemany L; Taberna M; Mena M; Tous S; Bagué S; Castellsagué X; Quer M; León X
Oral Oncol; 2017 Jan; 64():37-43. PubMed ID: 28024722
[TBL] [Abstract][Full Text] [Related]
39. A Prospective Cohort Study of Human Papillomavirus-Driven Oropharyngeal Cancers: Implications for Prognosis and Immunisation.
Wakeham K; Pan J; Pollock KG; Millan D; Bell S; McLellan D; McPhaden A; Conway DI; Graham SV; Kavanagh K; Cuschieri K
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e132-e142. PubMed ID: 31248692
[TBL] [Abstract][Full Text] [Related]
40. Using a semi-conductor sequencing-based panel for genotyping of HPV-positive and HPV-negative oropharyngeal cancer: a retrospective pilot study.
Ham JC; Tops BBJ; Driessen CML; van Raaij AWM; Slootweg PJ; Melchers WJG; Ligtenberg MJL; van Herpen CML
Clin Otolaryngol; 2017 Jun; 42(3):681-686. PubMed ID: 27882657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]